BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript
Source: SeekingAlpha
2026-03-05 03:22:11 ET
BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID March 4, 2026 4:15 PM EST...
Read the full article on Seeking Alpha
For further details see:
BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript
BioVie Inc. Warrant
NASDAQ: BIVIW
BIVIW Trading
0.0% G/L:
$0.35 Last:
1,000 Volume:
$0.35 Open:
BIVIW Latest News
BIVIW Stock Data
$8,750,542
7,475,679
N/A
13
N/A
Biotechnology & Life Sciences
Healthcare
US
Carson City
